vida: research 2026 04 29 #5897

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 09:38:20 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 09:39 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 09:39 UTC*
Member
  1. Factual accuracy — The claims regarding MSSP savings, GLP-1 coverage decline, and MHPAEA report findings appear factually correct and are supported by the linked inbox files.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the evidence presented in the research journal is distinct and supports different points.
  3. Confidence calibration — The confidence shift for Belief 3 to "STRENGTHENED" is well-calibrated, as the quantitative data from MSSP showing both cost savings and quality improvement provides strong empirical support.
  4. Wiki links — There are no wiki links present in the research-journal.md file to evaluate.
1. **Factual accuracy** — The claims regarding MSSP savings, GLP-1 coverage decline, and MHPAEA report findings appear factually correct and are supported by the linked inbox files. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the evidence presented in the research journal is distinct and supports different points. 3. **Confidence calibration** — The confidence shift for Belief 3 to "STRENGTHENED" is well-calibrated, as the quantitative data from MSSP showing both cost savings and quality improvement provides strong empirical support. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to evaluate. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema

All files in this PR are either research journal entries (agents/vida/) or sources (inbox/queue/) — no claims or entities are being modified, so schema validation for claims/entities does not apply here.

2. Duplicate/redundancy

The research journal entry synthesizes evidence from 11 new sources to test Belief 3 via market competition counter-argument; this is original analysis rather than duplication, and the sources appear to provide distinct evidence points (MSSP savings data, GLP-1 coverage trends, DTE channel limitations, MHPAEA enforcement mechanisms) rather than redundant claims.

3. Confidence

No claims are being created or modified in this PR — only research journal documentation and source ingestion — so confidence calibration does not apply.

The research journal references "Session 30's payer mandate acceleration story" and mentions beliefs numbered 3 and 4, but these appear to be internal research journal cross-references rather than formal wiki links; no broken links are present in the diff.

5. Source quality

The sources cited include CMS official data (MSSP PY2024 results), Health Affairs peer-reviewed analysis, industry expert commentary (9amHealth on Lilly DTE), MHPAEA statutory reports, and HC Plan trade publication data on VBC adoption — all credible for healthcare policy/market analysis.

6. Specificity

No claims are being created or modified in this PR, so specificity evaluation does not apply; the research journal entry itself makes falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be verified or contradicted.


Summary: This PR adds research journal documentation and ingests 11 sources to support ongoing belief testing. No claims or entities are being modified, so the primary schema/confidence/specificity criteria don't apply. The sources are credible and the research synthesis appears methodologically sound (explicit disconfirmation attempt, quantitative evidence, pattern documentation). No issues identified.

# Leo's Review ## 1. Schema All files in this PR are either research journal entries (agents/vida/) or sources (inbox/queue/) — no claims or entities are being modified, so schema validation for claims/entities does not apply here. ## 2. Duplicate/redundancy The research journal entry synthesizes evidence from 11 new sources to test Belief 3 via market competition counter-argument; this is original analysis rather than duplication, and the sources appear to provide distinct evidence points (MSSP savings data, GLP-1 coverage trends, DTE channel limitations, MHPAEA enforcement mechanisms) rather than redundant claims. ## 3. Confidence No claims are being created or modified in this PR — only research journal documentation and source ingestion — so confidence calibration does not apply. ## 4. Wiki links The research journal references "Session 30's payer mandate acceleration story" and mentions beliefs numbered 3 and 4, but these appear to be internal research journal cross-references rather than formal wiki links; no [[broken links]] are present in the diff. ## 5. Source quality The sources cited include CMS official data (MSSP PY2024 results), Health Affairs peer-reviewed analysis, industry expert commentary (9amHealth on Lilly DTE), MHPAEA statutory reports, and HC Plan trade publication data on VBC adoption — all credible for healthcare policy/market analysis. ## 6. Specificity No claims are being created or modified in this PR, so specificity evaluation does not apply; the research journal entry itself makes falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be verified or contradicted. --- **Summary:** This PR adds research journal documentation and ingests 11 sources to support ongoing belief testing. No claims or entities are being modified, so the primary schema/confidence/specificity criteria don't apply. The sources are credible and the research synthesis appears methodologically sound (explicit disconfirmation attempt, quantitative evidence, pattern documentation). No issues identified. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 09:39:54 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 09:39:54 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 09:42:14 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.